FDA Approved: CONJUGATED ESTROGENS — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA has approved a supplemental NDA for Conjugated Estrogens (Estrogens, Conjugated) from Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Menopause-related Vasomotor Symptoms
• Ovarian Failure
• Postmenopausal Osteoporosis
• Vulvar and Vaginal Atrophy

Drugs mentioned

• Conjugated Estrogens (ESTROGENS, CONJUGATED)

Snippet

SUPPL AP for CONJUGATED ESTROGENS (ESTROGENS, CONJUGATED)